FDA
-
-
-
-
-
-
-
Catalyst Pharmaceuticals Reports Record Fourth Quarter and Record Full Year 2025 Financial Results and Provides 2026 Financial Guidance
-
-
-
-
-
-
-
Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Catalyst Pharmaceuticals Reports Strong Third Quarter 2024 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Catalyst Pharmaceuticals Enters Into an Exclusive License, Supply and Commercialization Agreement with Kye Pharmaceuticals for AGAMREE® in Canada
-
-
-
-
-
-
-
Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May
-
-
-
-
-
-
-
Catalyst Pharmaceuticals to Participate at the Barclays 26th Annual Global Healthcare Conference
-
-
-
-
-
-
-
Catalyst Pharmaceuticals, Inc. Announces Closing of Public Offering
-
322,937 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

